As of 2024-07-27, the Relative Valuation of Amicus Therapeutics Inc (FOLD) is (15.38) USD. This relative valuation is based on P/E multiples. With the latest stock price at 10.18 USD, the upside of Amicus Therapeutics Inc based on Relative Valuation is -251.1%.
The range of the Relative Valuation is (15.29) - (15.49) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 30.8x - 31.8x | 31.3x |
| Forward P/E multiples | 30.1x - 31.2x | 30.6x |
| Fair Price | (15.29) - (15.49) | (15.38) |
| Upside | -250.2% - -252.2% | -251.1% |
| Date | P/E |
| 2024-07-26 | -20.50 |
| 2024-07-25 | -20.66 |
| 2024-07-24 | -20.85 |
| 2024-07-23 | -20.77 |
| 2024-07-22 | -20.71 |
| 2024-07-19 | -20.91 |
| 2024-07-18 | -21.45 |
| 2024-07-17 | -21.35 |
| 2024-07-16 | -21.83 |
| 2024-07-15 | -21.41 |
| 2024-07-12 | -20.97 |
| 2024-07-11 | -21.13 |
| 2024-07-10 | -20.81 |
| 2024-07-09 | -20.77 |
| 2024-07-08 | -20.48 |
| 2024-07-05 | -20.18 |
| 2024-07-03 | -19.76 |
| 2024-07-02 | -19.84 |
| 2024-07-01 | -19.74 |
| 2024-06-28 | -19.98 |
| 2024-06-27 | -19.96 |
| 2024-06-26 | -19.54 |
| 2024-06-25 | -19.88 |
| 2024-06-24 | -20.14 |
| 2024-06-21 | -20.32 |
| 2024-06-20 | -19.74 |
| 2024-06-18 | -19.68 |
| 2024-06-17 | -20.22 |
| 2024-06-14 | -20.42 |
| 2024-06-13 | -21.44 |
| 2024-06-12 | -21.43 |
| 2024-06-11 | -20.95 |
| 2024-06-10 | -20.24 |
| 2024-06-07 | -20.24 |
| 2024-06-06 | -20.68 |
| 2024-06-05 | -21.11 |
| 2024-06-04 | -20.38 |
| 2024-06-03 | -20.20 |
| 2024-05-31 | -19.74 |
| 2024-05-30 | -19.90 |
| 2024-05-29 | -18.85 |
| 2024-05-28 | -19.30 |
| 2024-05-24 | -19.46 |
| 2024-05-23 | -19.07 |
| 2024-05-22 | -19.58 |
| 2024-05-21 | -19.96 |
| 2024-05-20 | -19.64 |
| 2024-05-17 | -19.28 |
| 2024-05-16 | -19.13 |
| 2024-05-15 | -19.46 |